First-Time Generics - January 2003
| |
Generic Drug Name |
Generic Manufacturer |
Brand Name |
Approval Date |
| 1 |
STRONTIUM CHLORIDE Sr-89 INJECTION, USP 1 mCi/Ml |
BIO-NUCLEONICS PHARMA, INC. |
METASTRON INJECTION |
1/6/03 |
| 2 |
LORATADINE TABLETS (OTC) 10 MG |
GENEVA PHARMACEUTICALS, INC. |
CLARITIN TABLETS |
1/21/03 |
| 3 |
MIRTAZAPINE TABLETS 15 MG AND 30 MG |
TEVA PHARMACEUTICALS USA |
REMERON TABLETS |
1/24/03 |
| 4 |
ETIDRONATE DISODIUM TABLETS, USP 200 MG AND 400 MG |
GENPHARM INC. |
DIDRONEL TABLETS |
1/24/03 |
| 5 |
RILUZOLE TABLETS 50 MG |
IMPAX LABORATORIES, INC. |
RILUTEK TABLETS |
1/29/03 |
| 6 |
LORATADINE AND PSEUDOEPHEDRINE SULFATE EXTENDED-RELEASE TABL 5 MG/120 MG (12-HOUR FORMULATION) (OTC) |
IMPAX LABORATORIES |
CLARITIN-D 12-HOUR EXTENDED-RELEASE TABLETS |
1/30/03 |
| 7 |
BUTALBITAL, ACETAMINOPHEN, & CAFFEINE ORAL SOLUTION 50 MG/325 MG/40 MG, RESPECTIVELY, PER 15 ML |
MIKART, INC. |
FIORICET TABLETS |
1/31/03 |
 Back to Top 
Back to Approvals
FDA/Center for Drug Evaluation and Research
Last Updated: January 2, 2003
Originator: OTCOM/OGD
HTML by SJW
|
